• PBI3 The Economic Evaluation Of Clopidogrel In Antiplatelet Therapy Guided By CYP2C19 Gene Polymorphism In The Treatment Of Patients With Coronary Heart Disease

    Sep 1, 2020, 00:00

  • PCN4 Aromatase Inhibitors and Bisphosphonate Use in Postmenopausal Women with Hormone-Receptor Positive Breast Cancer in Hong Kong

    Sep 1, 2020, 00:00

  • PNS10 Economic Evaluation in the Philippines before the Era of Mandatory Health Technology Assessment: A Systematic Review

    Sep 1, 2020, 00:00

  • PCV5 Cost-Effectiveness Analysis of Apixaban in Treatment of Atrial Fibrillation: A Systematic Review

    Sep 1, 2020, 00:00

  • PDG18 Availability, Cost and Affordability of Selected Antibiotics and Antiviral Medicines Against Infectious Diseases from 2013 to 2019 in Nanjing, China

    Sep 1, 2020, 00:00

  • PNS51 The Role of Patients in Health Technology Assessment Process - Experience of Taiwan

    Sep 1, 2020, 00:00

  • PIN5 Evaluating Treatments and Corresponding Mortality Rates in Patients with Acinetobacter Baumannii Infections

    Sep 1, 2020, 00:00

  • PIN26 Assessment Of Influence Of Education To Parents Towards Completion Of Vaccination : A Randomised Controlled Study

    Sep 1, 2020, 00:00

  • PRS5 An Environment IMPACT Analysis of the Use of Respimat RE-Usable for the Treatment of Chronic-Obstructive Pulmonary Disorder (COPD) in South-EAST ASIA and South Korea

    Sep 1, 2020, 00:00

  • PNS13 Assessment of Satisfaction with New Competencies and Roles of Nurses in the Framework of Nursing Reform in Kazakhstan

    Sep 1, 2020, 00:00

  • PNS68 Valuating the CHILD Health Utility 9-Dimention in JAPAN: Results from a Nation-Wide School-Based Survey

    Sep 1, 2020, 00:00

  • PBI4 The ISSUE of Patient CO-Pay and Biosimilars in JPN: Is IT Really an ISSUE?

    Sep 1, 2020, 00:00

  • PMU7 Drug-Drug Interaction ( DDI ) Pharmacoeconomic Studies of Waste. Experience of a Single Institution Based on Rwd at a Private Health Insurance in LATAM

    Sep 1, 2020, 00:00

  • PIN20 Study on Disease Treatment Preference and Willingness Payment in Hepatitis C Patients

    Sep 1, 2020, 00:00

  • PCN93 A Comparison of Machine Learning (ML) Algorithms Performance Against Medical Professionals in Diagnosing LUNG Cancer: A Targeted Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PCN105 Investigating Medical Utilization in Ductal Carcinoma in Situ (DCIS) Women: A Real-World Data Analysis

    Sep 1, 2020, 00:00

  • PGI4 Projecting the Health Impact of Vaccination with Rotateq in China

    Sep 1, 2020, 00:00

  • PMS4 Epidemiology, Treatment Patterns, and Economic Burden of Postmenopausal Osteoporosis and Associated Fractures in China in 2017

    Sep 1, 2020, 00:00

  • PMS16 Longitudinal Analyses of Health-Related Quality of Life and Daily Activities Function Among HIP Fracture Population: A Real-World Prospective Cohort Study

    Sep 1, 2020, 00:00

  • PCN53 Cost-Utility Analysis of Dacomitinib As First-LINE Treatment for Patients with Locally Advanced or Metastatic NON-SMALL CELL LUNG Cancer in China

    Sep 1, 2020, 00:00

  • PCN13 Comparison of Nab-paclitaxel PLUS Gemcitabine Versus S-1 PLUS Gemcitabine in First LINE Treatment of Metastatic Pancreatic Cancer in China: A Cost-Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PMH7 Depression and Insomnia at Burapha University, Thailand 2019

    Sep 1, 2020, 00:00

  • PCN23 Cost-Effectiveness Analysis of Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride, and paclitaxel As Second-LINE Chemotherapy in the Treatment of Platinum-Resistant Ovarian Cancer in Iran

    Sep 1, 2020, 00:00

  • PCN86 Predicting the Unknown - How Health Technology Assessment Agencies Deal with Uncertainty, and the IMPACT This HAS on Patient Access for Immuno-Oncology Therapies

    Sep 1, 2020, 00:00

  • PCN24 Budget IMPACT Analysis (BIA) of Introducing Tisagenlecleucel for the Treatment of Patients with Relapsed and Refractory Diffuse Large B-CELL Lymphoma (R/R DLBCL) in Singapore (SG)

    Sep 1, 2020, 00:00

  • PCN88 HTA Evaluations of Oncology Drugs in APAC - Comparison of Trends and Drivers of Success in 5 Countries

    Sep 1, 2020, 00:00

  • PUK4 Cost-Effectiveness of Robotic-Assisted Partial Nephrectomy

    Sep 1, 2020, 00:00

  • PMS5 Incidence and Risk Factors for Subsequent Osteoporotic Fracture: A Nationwide Cohort Study in South Korea

    Sep 1, 2020, 00:00

  • PMD14 Economic Analysis to Evaluate IMPACT of Prostheses Choice in Primary TOTAL Knee Arthroplasty

    Sep 1, 2020, 00:00

  • PIH14 Perception of Seriousness, Knowledge, and Willingness to Pay for Cervical Cancer Screening Among Women in Yogyakarta Province, Indonesia

    Sep 1, 2020, 00:00

  • PCN101 Healthcare Resource Utilization, Costs, and Clinical Outcomes in Patients with Triple-Negative Breast Cancer in Northern Thailand: A Real World Evidence Using Electronic Health Records

    Sep 1, 2020, 00:00

  • PCN43 Disease Burden of NON-SMALL CELL Cancer UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMS2 Disease Burden of Subsequent Fracture in Osteoporosis Patients in South Korea

    Sep 1, 2020, 00:00

  • PMH15 Children with Deficit in Executive Abilities Have a Risk for Emerging Weakness in Grammar Understanding

    Sep 1, 2020, 00:00

  • PND7 Cost-Effectiveness of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Kazakhstan

    Sep 1, 2020, 00:00

  • PMU17 Health Technology Assessment for Procedures: The Evaluation of Innovation in JAPAN

    Sep 1, 2020, 00:00

  • PCN74 Analyze Oncology Drug Price Change in the Chinese Market through National Reimbursement Drug LIST Negotiation

    Sep 1, 2020, 00:00

  • PNS30 IMPACT of Cigarette Tax on Youth Smoking in Taiwan

    Sep 1, 2020, 00:00

  • The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect? [Editor's Choice]

    Sep 1, 2020, 00:00

  • PIN24 Disease Burden of Progressive Chronic Hepatitis C in China

    Sep 1, 2020, 00:00

  • PCV11 Cost-Effectiveness of Intravascular Ultrasound (IVUS) during Drug-Eluting Stent Implantation in Korea

    Sep 1, 2020, 00:00

  • PCN58 Frequency of Myalgia in Patients Receiving Platinum Based Chemotherapy

    Sep 1, 2020, 00:00

  • PDG27 The Complexity and Cost of Drug Regimens for Hypertensive Patients in China

    Sep 1, 2020, 00:00

  • Copyright/Subscription

    Jun 3, 2020, 09:04

  • Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

    May 1, 2020, 00:00

  • Addressing the Cost Data Gap for Universal Healthcare Coverage in India: A Call to Action

    May 1, 2020, 00:00

  • From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review

    May 1, 2020, 00:00

  • The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

    May 1, 2020, 00:00

  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals

    May 1, 2020, 00:00

  • Complicated Issues of Medical Examination: A Case Study of the Irkutsk Region

    May 1, 2020, 00:00

  • Causes of Under-5 Mortality Among Brazil, the Russian Federation, India, China, and South Africa Nations: A Comparative Study

    May 1, 2020, 00:00

  • Tackling the 3 Big Challenges Confronting Health Technology Assessment Development in Asia: A Commentary

    May 1, 2020, 00:00

  • Economic Evaluation of Breast Cancer Early Detection Strategies in Asia: A Systematic Review [Editor's Choice]

    May 1, 2020, 00:00

  • Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data

    May 1, 2020, 00:00

  • Relationships Between Pharmaceutical Therapy–Related Quality of Life and Health Utility Scores in Thai Patients With Chronic Diseases

    May 1, 2020, 00:00

  • Determining the Cost and Length of Stay at Intensive Care Units and the Factors Influencing Them in a Teaching Hospital in Malaysia

    May 1, 2020, 00:00

  • Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120 mmHg in Hypertensive Patients Without Diabetes Mellitus

    May 1, 2020, 00:00

  • Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand

    May 1, 2020, 00:00

  • Editorial Board

    May 1, 2020, 00:00

  • The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System [Editor's Choice]

    May 1, 2020, 00:00

  • Comparative Analysis of Prescription Drug Prices in South Asian Association for Regional Cooperation Countries

    May 1, 2020, 00:00

  • Inappropriate Rate of Admission and Hospitalization in the Iranian Hospitals: A Systematic Review and Meta-Analysis

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Prostate-Specific Antigen Screening Among Chinese Men

    May 1, 2020, 00:00

  • Translation, Cultural Adaptation, and Validation of Short-Form 6D on the General Population in Indonesia

    May 1, 2020, 00:00

  • The Economic Burden of Candidemia and Invasive Candidiasis: A Systematic Review

    May 1, 2020, 00:00

  • Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol

    May 1, 2020, 00:00

  • Budget Impact Analysis of Extended-Release Phenytoin Capsules Compared With Immediate-Release Phenytoin Capsules for Patients With Epilepsy in Thailand

    May 1, 2020, 00:00

  • Estimation of Quality-Adjusted Life Expectancy of Patients With Oral Cancer: Integration of Lifetime Survival With Repeated Quality-of-Life Measurements

    May 1, 2020, 00:00

  • Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia

    May 1, 2020, 00:00

  • Power of 1 Malaysian Ringgit: A Low-Cost Prescription Cost-Sharing Model in Malaysia

    May 1, 2020, 00:00

  • Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai Patients With End-Stage Renal Disease

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Xpert MTB/RIF for Multi-Outcomes of Patients With Presumptive Pulmonary Tuberculosis in Thailand [Editor's Choice]

    May 1, 2020, 00:00

  • A Systematic Review of Equity in Healthcare Financing in Low- and Middle-Income Countries

    May 1, 2020, 00:00

  • Assessing the Low Influenza Vaccination Coverage Rate Among Healthcare Personnel in India: A Review of Obstacles, Beliefs, and Strategies

    May 1, 2020, 00:00

  • Kidney Disease–Specific Scores and Health Utility of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients and Their Caregivers

    May 1, 2020, 00:00

  • Drug Selection for Formulary Inclusion: An Exploratory Case Study of Oncology Medicines in Jordan

    May 1, 2020, 00:00

  • Association of Socioeconomic Status With Childhood Anemia Among Infant, Toddler, and Preschool Children in Bangladesh

    May 1, 2020, 00:00

  • Survey on Willingness to Pay for Life-Saving Treatment, Functional Recovery, and Cosmesis in a Neuroscience Outpatient Clinic Setting in Singapore [Editor's Choice]

    May 1, 2020, 00:00

  • The Development of Health Technology Assessment in Asia: Current Status and Future Trends [Editor's Choice]

    May 1, 2020, 00:00

  • Table of Contents

    May 1, 2020, 00:00

  • Cross-Cultural Adaptation and Psychometric Analysis of the Persian Version of the ICEpop CAPability Measure for Adults Capability Measure in the Iranian General Population

    May 1, 2020, 00:00

  • Population Aging, Technological Innovation, and the Growth of Health Expenditure: Evidence From Patients With Type 2 Diabetes in Taiwan

    May 1, 2020, 00:00

  • The Factors Associated With Direct Medical Costs in Patients With Gastric Cancer: Quantile Regression Approach Compared With Gamma Regression

    May 1, 2020, 00:00

  • Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment

    May 1, 2020, 00:00

  • The Structure and Parameterization of the Breast Cancer Transition Model Among Chinese Women

    May 1, 2020, 00:00

  • Copyright/Subscription

    Dec 16, 2019, 08:54

  • Budgetary Impact of Oral Rehabilitation With Complete Dentures: An Economical Evaluation From São Paulo State, Brazil

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Proton Versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume–Based Analysis

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective

    Dec 1, 2019, 00:00

  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective

    Dec 1, 2019, 00:00

  • Determining the Operating Costs of a Medical Surveillance Program for Copper Miners Exposed to High Altitude–Induced Chronic Intermittent Hypoxia in Chile Using a Combination of Microcosting and Time-Driven Activity-Based Costing

    Dec 1, 2019, 00:00

  • Response to Letter to the Editor

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of a Technology-Enhanced Diabetes Care Management Program in Mexico

    Dec 1, 2019, 00:00

  • Editorial Board

    Dec 1, 2019, 00:00

  • The Brazilian Portuguese Version of the DISCERN Instrument: Translation Procedures and Psychometric Properties

    Dec 1, 2019, 00:00

  • Burden of Disease Attributable to Obesity and Overweight in Colombia

    Dec 1, 2019, 00:00

  • The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico [Editor's Choice]

    Dec 1, 2019, 00:00

  • Inflammatory Bowel Disease in Latin America: A Systematic Review

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Agnet y Judicialization en Salud en Argentina

    Dec 1, 2019, 00:00

  • Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology “Ignacio Chávez”

    Dec 1, 2019, 00:00

  • Prevalence of Symptoms and Symptom Clusters of Patients on Dialysis in Uruguay

    Dec 1, 2019, 00:00

  • Acuerdos de Riesgo Compartido: Lecciones Para su Diseño e Implementación a la Luz de la Experiencia Internacional

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia

    Dec 1, 2019, 00:00

  • Custo-utilidade de terapias-alvo comparadas à dacarbazina para o tratamento de primeira linha do melanoma avançado não-cirúrgico e metastático no Sistema Único de Saúde do Brazil

    Dec 1, 2019, 00:00

  • The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia [Editor's Choice]

    Dec 1, 2019, 00:00

  • A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population [Editor's Choice]

    Dec 1, 2019, 00:00

  • Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia

    Dec 1, 2019, 00:00

  • New Challenges in Oncology for the Brazilian Private Health Sector: Specialists' Concerns After the ISPOR International Congress in Boston, Massachusetts, 2017

    Dec 1, 2019, 00:00

  • Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y Venezuela

    Dec 1, 2019, 00:00

  • The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina

    Dec 1, 2019, 00:00

  • Budget Impact of Cryoablation Versus Radiofrequency Ablation of Atrial Fibrillation in the Brazilian Public Healthcare System

    Dec 1, 2019, 00:00

  • Beneficio económico de los ensayos clínicos controlados patrocinados: El gasto evitable en medicamentos para el tratamiento de la artritis reumatoidea

    Dec 1, 2019, 00:00

  • Health Economics and Outcomes Research Knowledge Needs Assessment for Latin America [Editor's Choice]

    Dec 1, 2019, 00:00

  • Table of Contents

    Dec 1, 2019, 00:00

  • Costo de la intoxicación por Paraquat en Colombia

    Dec 1, 2019, 00:00

  • Challenges in the Regulation of High-Cost Treatments: An Overview From Brazil [Editor's Choice]

    Dec 1, 2019, 00:00

  • The Price of Substitute Technologies

    Dec 1, 2019, 00:00

  • Economic Cost of Severe Acute Respiratory Infection Associated to Influenza in Colombian Children: A Single Setting Analysis

    Dec 1, 2019, 00:00

  • PIN20 OVERVIEW OF MORTALITY DUE TO ANTIMICROBIAL RESISTANT INFECTIONS

    Oct 1, 2019, 00:00

  • PRO9 PUBLIC PURCHASES OF ECULIZUMABE BY THE BRAZILIAN MINISTRY OF HEALTH: A PROFILE OF VOLUMES AND EXPENSES FROM 2007 TO 2018

    Oct 1, 2019, 00:00

  • PCN24 COST-EFFECTIVENESS OF NIVOLUMAB COMBINED WITH IPILIMUMAB IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA FOR PATIENTS WITH BRAF+ MUTATION FROM A BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PNS3 BRAZILIAN PHARMACEUTICAL INDUSTRY: THE IMPACT OF PUBLIC POLICIES AIMED AT FOSTERING LOCAL MANUFACTURING

    Oct 1, 2019, 00:00

  • PDG10 DRUGS WITH DISCONTINUED PRODUCTION: A DESCRIPTIVE ANALYSIS OF THE BRAZILIAN SCENARIUM

    Oct 1, 2019, 00:00

  • PNS15 DOES FOOD INSECURITY AFFECT PERFORMANCE AT SCHOOL? EVIDENCE FROM BRAZIL

    Oct 1, 2019, 00:00

  • PIN26 PRINCIPALES ESQUEMAS ANTIRRETROVIRALES USADOS EN LAS PERSONAS QUE VIVEN CON EL VIH EN COLOMBIA. 2018

    Oct 1, 2019, 00:00

  • PNS45 APPLYING A RAPID REVIEW METHODOLOGY TO INFORM THE UPDATE OF ARGENTINA'S HEALTH BENEFIT PACKAGE

    Oct 1, 2019, 00:00

  • PRO11 ANÁLISIS DE SERIE DE CASOS DE PACIENTES CON DIAGNÓSTICO DE HEMOFILIA A CON INHIBIDORES EN HOSPITALES DE ALTA COMPLEJIDAD EN ECUADOR

    Oct 1, 2019, 00:00

  • PDG1 POLIMIXINA B: EXISTEM FATORES DE RISCO ASSOCIADOS À NEFROTOXICIDADE EM PACIENTES QUE UTILIZARAM ESTE MEDICAMENTO?

    Oct 1, 2019, 00:00

  • PCN30 REAL-WORLD DATA FOR COSTS RELATED TO CANCER MANAGEMENT IN BRAZIL: AN OVERVIEW OF THE LITERATURE

    Oct 1, 2019, 00:00

  • PIN23 EVALUACIÓN DE LAS PROPIEDADES PSICOMÉTRICAS DEL EQ-5D-5L EN PACIENTES CON VIH/SIDA EN COLOMBIA

    Oct 1, 2019, 00:00

  • PND9 BUDGET IMPACT ANALYSIS OF CLADRIBINE COMPARED TO THE CURRENT COVERAGE SCHEME IN CHILE TO TREAT PATIENTS WITH HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS

    Oct 1, 2019, 00:00

  • MT4 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN LA COBERTURA DE LAS OBRAS SOCIALES NACIONALES DE ARGENTINA

    Oct 1, 2019, 00:00

  • PDB10 COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN TYPE 1 DIABETES MELLITUS COMPARED WITH MULTIPLE DAILY INJECTIONS IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PCN13 EVENTOS ADVERSOS ASOCIADOS A LOS TRATAMIENTOS DEL CARCINOMA UROTERIAL DE VEJIGA Y EL CARCINOMA DE CELULAS RENALES: ESTIMACION DE COSTOS DIRECTOS PARA ARGENTINA

    Oct 1, 2019, 00:00

  • HI4 ADHERENCE TO TREATMENT IS ASSOCIATED WITH GOOD CLINICAL RESULTS IN PATIENTS TREATED WITH BIOLOGICAL THERAPY IN A CENTER OF EXCELLENCE IN RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PND12 WORK PRODUCTIVITY AND DAILY ACTIVITIES IMPAIRMENT (WPAI) IN CHILEAN PATIENTS WITH MIGRAINE: PERSPECTIVES ON INDIRECT-COSTS DRIVERS

    Oct 1, 2019, 00:00

  • PIN4 A BUDGET IMPACTO ANALYSIS OF TENOFOVIR ALAFENAMIDE/EMTRICITABINE (DESCOVY®) FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN PATIENTS AGED 12 YEARS AND OLDER, IN MEXICO

    Oct 1, 2019, 00:00

  • PND4 ANALISIS DE MINIMIZACION DE COSTOS DE TOPIRAMATO DE LIBERACION PROLONGADA PARA LA PREVENCION DE MIGRAÑA EN ADULTOS Y ADOLESCENTES A PARTIR DE LOS 12 AÑOS

    Oct 1, 2019, 00:00

  • PCN39 ACCESS TO MEDICAL INTERVENTIONS IN BRAZIL: THE ROLE OF CLINICAL RESEARCH AND OF HEALTH JUDICIALIZATION

    Oct 1, 2019, 00:00

  • PNS59 IMPACTO DEL MODELO DE RIESGO COMPARTIDO EN LA TASA DE EVENTOS HOSPITALARIOS DE UN SEGURO VOLUNTARIO EN COLOMBIA

    Oct 1, 2019, 00:00

  • PRO14 COMPARAR A INCIDÊNCIA DE COMORBIDADES NO TRATAMENTOS DE MIELOMA MÚLTIPLO ENTRE AS TERAPIAS DO SISTEMA DE SAÚDE BRASILEIRO (SUS) COM AS AINDA NÃO INCORPORADAS

    Oct 1, 2019, 00:00

  • PUK7 ANALISIS DE EFECTIVIDAD Y SEGURIDAD DE MIRABEGRON EN PACIENTES CON SINDROME DE VEJIGA HIPERACTIVA

    Oct 1, 2019, 00:00

  • PCN44 DESIGUALDADES EN EL DIAGNÓSTICO DE CÁNCER DE CÉRVIX EN LAS REGIONES DE COLOMBIA

    Oct 1, 2019, 00:00

  • PGI5 BURDEN OF LIVER DISEASE, COLOMBIA 2009-2016

    Oct 1, 2019, 00:00

  • HI1 PRELIMINARY COST ANALYSIS OF MISDIAGNOSIS OF RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PIH2 COST-EFFECTIVENESS ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • MT2 REMOTE MONITORING COMPARED TO CONVENTIONAL FOLLOW-UP FOR PATIENTS WITH HEART FAILURE USING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR: A BUDGET IMPACT ANALYSIS

    Oct 1, 2019, 00:00

  • PMS8 CONVENTIONAL VERSUS BIOLOGICAL TREATMENT FOR ANKYLOSING SPONDYLITIS. RESULTS FROM A REAL-LIFE SETTING

    Oct 1, 2019, 00:00

  • PMH10 TREATMENT-RESISTANT DEPRESSION IN LATIN AMERICA: PRELIMINARY RESULTS FROM THE TRAL STUDY

    Oct 1, 2019, 00:00

  • PMS10 NATIONWIDE ANNUAL HEALTH INSURANCE TREATMENT COST OF JUVENILE AND ADOLESCENT IDIOPATHIC SCOLIOSIS IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • PMU9 ESTABLISHING CHILE RICARTE SOTO LAW REIMBURSEMENT CAP IN THE FACE OF GENERIC COMPETITION

    Oct 1, 2019, 00:00

  • PCV2 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN ARGENTINA: META-ANALYSIS OF REAL-LIFE DATA

    Oct 1, 2019, 00:00

  • PAM2 GESTION DE SOPORTE NUTRICIONAL EN CUIDADOS INTENSIVOS

    Oct 1, 2019, 00:00

  • PAM6 COMPLEMENTARY AND INTEGRATIVE THERAPIES IN BRAZIL'S UNIFIED HEALTHCARE SYSTEM (SUS) IN 2017: AN UNDERREPORTING CASE

    Oct 1, 2019, 00:00

  • PCN15 IMPACTO ECONOMICO DE LAS COMPLICACIONES OSEAS EN PACIENTES CON CANCER DE MAMA METASTASICO (CAMM) EN MEXICO.

    Oct 1, 2019, 00:00

  • PMH6 COST-EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS FOR FIRST- AND SECOND-LINE TREATMENT OF SCHIZOPHRENIA IN BRAZIL

    Oct 1, 2019, 00:00

  • PCN20 COSTO EFECTIVIDAD DE LA UTILIZACIÓN DE INHIBIDORES DE PUNTOS DE CONTROL INMUNITARIO (ANTI-PD1/ANTI-CTLA4) Y TERAPIAS DIRIGIDAS (BRAFI/MEKI) EN EL TRATAMIENTO DEL MELANOMA AVANZADO.

    Oct 1, 2019, 00:00

  • PRO1 MEDICAL THERAPY FOR PULMONARY ARTERIAL HYPERTENSION (PAH): AN INDIRECT TREATMENT COMPARISON OF MACITENTAN AND BOSENTAN

    Oct 1, 2019, 00:00

  • PNS20 REPORTS OF SUBSTANDARD MEDICINES: AN ANALYSIS OF THE BRAZILIAN HEALTH SURVEILLANCE NOTIFICATION SYSTEM

    Oct 1, 2019, 00:00

  • PIH8 MODEL TO APPROACH TO THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY IN CHILE: THE IMPACT OF THE FAILURE OF COMPLIANCE OF THE CONTRACEPTIVE METHODS.

    Oct 1, 2019, 00:00

  • PCN23 IMPACTO ECONOMICO DE CANCER DE CUELLO UTERINO Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PNS10 THE PENALTY OF MATERNITY FOR LABOR MARKET IN BRAZIL

    Oct 1, 2019, 00:00

  • PND14 OUT-OF-POCKET EXPENDITURE IN MIGRAINE PATIENTS WITH AND WITHOUT COMORBIDITIES IN CHILE: A HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PCN33 PERTUZUMAB+TRASTUZUMAB TREATMENT ON HER2+ EARLY BREAST CANCER: LONG-TERM REDUCTION OF METASTASIC BREAST CANCER INCIDENCE IN ARGENTINA.

    Oct 1, 2019, 00:00

  • PIN10 PUBLIC HEALTH AND ECONOMIC IMPACT OF A HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR

    Oct 1, 2019, 00:00

  • PMS17 PATIENT PREFERENCES FOR BIOLOGIC AND BIOSIMILAR OSTEOPOROSIS TREATMENTS IN COLOMBIA: A DISCRETE-CHOICE EXPERIMENT

    Oct 1, 2019, 00:00

  • PNS7 THE PRICE OF SUBSTITUTE TECHNOLOGIES

    Oct 1, 2019, 00:00

  • PMU13 A MULTI-CRITERIA APPROACH TO THE STUDY OF CHRONIC NON-COMMUNICABLE DISEASES IN BRAZIL

    Oct 1, 2019, 00:00

  • PSU6 ESTUDIO DE COSTO EFECTIVIDAD ENTRE HEPARINA NO FRACCIONADA Y HEPARINAS DE BAJO PESO MOLECULAR EN PACIENTES SOMETIDOS A ARTROPLASTIA TOTAL DE CADERA ELECTIVA

    Oct 1, 2019, 00:00

  • CV1 CARDIOVASCULAR RISK IN DIABETES PATIENTS MONITORED BY A MOBILE PHONE APP HEALTH CARE PROGRAM IN BRAZIL

    Oct 1, 2019, 00:00

  • PMD13 BUNDLE AND RISK SHARING FOR BARIATRIC SURGERY UNDER THE VALUE-BASED CARE (VBC) MODEL: MODEL EFFECTIVENESS AND SUSTAINABILITY AT HOSPITAL ALEMAO OSWALDO CRUZ (HAOC) BASED IN CLINICAL AND ECONOMICAL RESULTS

    Oct 1, 2019, 00:00

  • PNS43 ESTIMACIÓN DE UN COSTO DE REFERENCIA PARA EVENTOS HOSPITALARIOS MEDIANTE NORMALIZACIÓN DE DATOS

    Oct 1, 2019, 00:00

  • PBI1 THE VALUE OF ONASEMNOGENE ABEPARVOVEC (AVXS-101) AS A COST-EFFECTIVE GENE REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 IN IMPROVING SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND MOTOR FUNCTION

    Oct 1, 2019, 00:00

  • PCV6 ECONOMIC EVALUATION OF GLOBAL LONGITUDINAL STRAIN IN THE EARLY DETECTION OF CARDIOTOXICITY IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PCN42 JUDICIALIZATION OF ACCESS TO MEDICINES IN ONCOLOGY: SYSTEMATIZED REVIEW

    Oct 1, 2019, 00:00

  • PIN28 COSTS OF PERTUSSIS IN BRAZIL: A NINE-YEAR EVALUATION

    Oct 1, 2019, 00:00

  • PND6 THE DIRECT COSTS OF MULTIPLE SCLEROSIS IN A GROUP OF COLOMBIAN PATIENTS

    Oct 1, 2019, 00:00

  • PBI3 ANÁLISIS DEL COSTO POR RESPONDEDOR DE SECUKINUMAB VS INFLIXIMAB Y ETANERCEPT PARA EL TRATAMIENTO DE LA ARTRITIS PSORIÁSICA DESDE UNA PERSPECTIVA ECUATORIANA

    Oct 1, 2019, 00:00

  • PCN14 COSTOS INDIRECTOS DEL CANCER DE MAMA EN COLOMBIA: 1990-2016.

    Oct 1, 2019, 00:00

  • PCN3 BRAND-BRAND ONCOLOGY COMBINATIONS: HURDLES AND IMPLICATIONS

    Oct 1, 2019, 00:00

  • PIN27 USO DE LA REGRESIÓN BETA EN EL ANALISIS DE ASOCIACIÓN ENTRE LOS ÍNDICES EQ-5D-5L, EQ-EVA Y POTENCIALES COVARIABLES EN PACIENTES CON VIH/SIDA EN COLOMBIA

    Oct 1, 2019, 00:00

  • PMU10 RESULTADOS DE IMPLEMENTACION DE PROGRAMA DE CUIDADOS PALIATIVOS EN UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN16 COST ESTIMATE ANALYSIS OF ABIRATERONE PLUS PREDNISONE (AAP) AND ENZALUTAMIDE (ENZ) IN INSURED METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS IN ARGENTINA: EVIREPRO DATABASE

    Oct 1, 2019, 00:00

  • PNS22 DESCRIBING GAPS IN ACCESS TO HEALTHCARE BETWEEN INTERNATIONAL MIGRANTS AND THE CHILEAN-BORN POPULATION

    Oct 1, 2019, 00:00

  • PNS12 THE IMPACT OF THE POSTPONEMENT OF MATERNITY ON WOMEN'S INCOME IN BRAZIL

    Oct 1, 2019, 00:00

  • PRO3 DIRECT COSTS OF HEMOPHILIA CARE, THE CASE OF A HEALTH INSURER IN COLOMBIA

    Oct 1, 2019, 00:00

  • PMS13 A ROUTE FOR THE CORRECT DIAGNOSIS OF RHEUMATOID ARTHRITIS - AN OPPORTUNITY TO AVOID MISDIAGNOSIS AND COSTS ASSOCIATED

    Oct 1, 2019, 00:00

  • PND19 RETROSPECTIVE ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT PROFILE AND PATTERNS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • PSU5 ANALISIS COSTE CONSECUENCIA DEL TRASPLANTE DE PROGENITORES HEMATOPOYETICOS DE DONANTE NO RELACIONADO FINANCIADO POR EL FONDO INTANGIBLE SOLIDARIO DE SALUD DEL PERU

    Oct 1, 2019, 00:00

  • PIN15 PUBLIC HEALTH IMPACT OF DENGUE VACCINATION WITH SCREENING IN BRAZIL

    Oct 1, 2019, 00:00

  • PMD3 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SANATORIO FINOCHIETTO DE ARGENTINA

    Oct 1, 2019, 00:00

  • MT3 ICD THERAPY FOR SUDDEN CARDIAC ARREST PREVENTION IS POTENTIALLY COST-EFFECTIVE IN THE 1.5 PRIMARY PREVENTION POPULATION IN COLOMBIA: AN ECONOMIC EVALUATION OF THE IMPROVED SCA STUDY

    Oct 1, 2019, 00:00

  • PMD1 PATIENT OUTCOMES IN CENTRIFUGE AND MEMBRANE THERAPEUTIC PLASMA EXCHANGE (TPE): LITERATURE REVIEW WITH A FOCUS ON THE CHILEAN COLOMBIAN MARKETS

    Oct 1, 2019, 00:00

  • PDB7 COST COMPARISON OF BOVINE PERICARDIUM (BP) VS. BIOCOMPATIBLE GLYCOLIDE COPOLYMER BUTTRESS IN GASTRIC STAPLE LINE REINFORCEMENT (SLR)

    Oct 1, 2019, 00:00

  • PGI3 IMPACT OF DOSE ESCALATION ON TREATMENT COST OF IMMUNOBIOLOGICAL THERAPIES FOR CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PCV13 EFECTIVIDAD DEL CATETER VENOSO DE INSERCION CENTRAL VS EL CATETER VENOSO CENTRAL DE INSERCION PERIFERICA EN EL TRATAMIENTO DE PACIENTES EN LA UNIDAD DE CUIDADOS INTENSIVOS.

    Oct 1, 2019, 00:00

  • CE3 ECONOMIC EVALUATION OF THE USE OF PRE-FILLED SYRINGE VERSUS MANUALLY FILLED SYRINGE PARAFLUSHING IN PATIENTS WITH CENTRAL VENOUS CATHETER IN THE PERSPECTIVE OF HEALTH CAREERS

    Oct 1, 2019, 00:00

  • PCN63 COSTOS ASOCIADOS AL MANEJO DE PACIENTES CON CARCINOMA HEPATOCELULAR EN EL REGIMEN CONTRIBUTIVO

    Oct 1, 2019, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
  • »